Skip to main content

Table 4 Clinicopathological variables of ruptured HCC patients who underwent hepatectomy with one-time hepatic inflow occlusion(one-HIO) and two times hepatic inflow occlusion(two-HIO)

From: The effect of the number of hepatic inflow occlusion times on the prognosis of ruptured hepatocellular carcinoma patients after hepatectomy

Variables

One time hepatic inflow occlusion

Two times hepatic inflow occlusion

p-value

n = 78

n = 25

Gender (%)

  

0.077

 Male

74 (94.9)

21 (84.0)

 

 Female

4 (5.1)

4 (16.0)

 

Age (y)

43.9 ± 11.4

39.1 ± 11.0

0.498

Length (%)

  

0.061

  ≤ 5 cm

20 (25.6)

2 (8.0)

 

  > 5 cm

58 (74.4)

23 (92.0)

 

Tumor number (%)

  

0.567

 Single

58 (74.4)

20 (80.0)

 

 Multiple

20 (25.6)

5 (20.0)

 

BCLC stage (%)

  

0.2

 A

41 (52.6)

8 (32.0)

 

 B

17 (21.8)

8 (32.0)

 

 C

20 (25.6)

9 (36.0)

 

Child–Pugh (%)

  

0.654

 A

59 (75.6)

20 (80.0)

 

 B

19 (24.4)

5 (20.0)

 

AFP (%)

  

0.093

  ≤ 400 ng/ml

31 (39.7)

5 (20.0)

 

  > 400 ng/ml

47 (60.3)

21 (84.0)

 

Edmondson-steiner (%)

  

0.115

 I

7 (9.0)

1 (4.0)

 

 II

45 (57.7)

9 (36.0)

 

 III

14 (17.9)

7 (28.0)

 

 IV

12 (15.4)

8 (32.0)

 

Necrosis (%)

  

0.136

 No

64 (82.1)

17 (68.0)

 

 Yes

14 (17.9)

8 (32.0)

 

Local invasion (%)

  

0.188

 No

43 (55.1)

10 (40.0)

 

 Yes

35 (44.9)

15 (60.0)

 

ALB (g/L)

35.6 (31.3–38.1)

36.5 (34.3–43.5)

0.053

ALT (U/L)

27.0 (20.5–41.8)

30.0 (24.0–49.0)

0.636

AST (U/L)

35.0 (22.0–65.3)

50.0 (31.5–80.0)

0.017

ALP (U/L)

77.0 (61.0–91.3)

72.0 (61.5–98.0)

0.661

GGT (U/L)

55.5 (36.0–122.3)

58.0 (29.5–147.5)

0.929

HBsAg (%)

  

0.881

 No

7 (9.0)

2 (8.0)

 

 Yes

71 (91.0)

23 (92.0)

 
  1. BCLC, Barcelona Clinic Liver Cancer; AFP, alpha fetoprotein; ALB, albumin; ALT, alanine aminotransferase; AST, aspartate aminotransferase; ALP, alkaline phosphatase; GGT, Îł-glutamyl transpeptidase; HIO, hepatic inflow occlusion